Go to Search

We're an international group of researchers tracking the progress of COVID-19 clinical trials. Groups around the world are beginning trials for vaccines, novel therapeutics, and repurposed drugs, but it's hard to see the forest from the trees. We collect data from global registries and provide simple analysis to give researchers and the public an idea of how development is going on multiple fronts.

This project is a collaboration between researchers at Stanford, MIT, and around the world. Join us by clicking here. All feedback welcome!

Jan Liphardt Laura Deming Dennis Wall Shivon Zilis
Jan Liphardt Laura Deming Dennis Wall Shivon A. Zilis
Stanford University The Longevity Fund Stanford University Neuralink
Ankit Ranjan Gautam Mittal Noah Saso Ethan Houston
Ankit Ranjan Gautam Mittal Noah Saso Ethan Houston
University of Oxford UC Berkeley UC Berkeley UT Austin
Nikhil D'Souza
Nikhil D'Souza
Purdue University

How can I help?

We collect COVID-19 clinical trial records from multiple global registries and are now building visualization tools to synthesize this work. Contact us with feedback and suggestions. Feverbase is entirely open source, and we always appreciate engineering support!

What will we do with the data?

We want to answer two questions:

  1. What treatments should clinicians use to prevent or treat COVID-19?
  2. What drug manufacturing does society need to invest in to best beat COVID-19?

All parts of our analysis are going to be public, so everyone can benefit. If you would like to help analyze the data, please reach out. We will be releasing results periodically after analysis and a quality review of the data.